Abstract
In a double-blind study, bronchiolitis associated with respiratory syncytial virus infection in 12 randomly selected patients treated with ribavirin aerosol improved more rapidly than in 14 control patients given saline aerosol (P = .044, Wilcoxon rank sum test, two-tailed). An estimated 10 mg of ribavirin per kilogram of body weight was administered in daily 12-hour treatments over a five-day period. Respiratory syncytial virus disappeared from secretions at about the same rate in treated and control patients. There was no local or systemic intolerance, and there was no evidence of hematologic or other organ toxicity in the ribavirin-treated patients.
- Received October 27, 1982.
- Accepted January 14, 1983.
- Copyright © 1983 by the American Academy of Pediatrics
Individual Login
Institutional Login
You may be able to gain access using your login credentials for your institution. Contact your librarian or administrator if you do not have a username and password.
Log in through your institution
Pay Per Article - You may access this article (from the computer you are currently using) for 2 days for US$25.00
Regain Access - You can regain access to a recent Pay per Article purchase if your access period has not yet expired.
In this issue
Jump to section
Related Articles
Cited By...
- Respiratory syncytial virus infection in adults
- Observer bias in randomized clinical trials with measurement scale outcomes: a systematic review of trials with both blinded and nonblinded assessors
- Diagnosis and Management of Bronchiolitis
- Animal Pneumoviruses: Molecular Genetics and Pathogenesis
- Systemic Corticosteroids in Infant Bronchiolitis: A Meta-analysis
- Perspectives for the Treatment of Infections withFlaviviridae
- Inhibition of Borna Disease Virus Replication by Ribavirin
- Randomised controlled trial of budesonide for the prevention of post-bronchiolitis wheezing
- Respiratory Syncytial Virus Infection: Immune Response, Immunopathogenesis, and Treatment
- Efficacy of RD3-0028 Aerosol Treatment against Respiratory Syncytial Virus Infection in Immunosuppressed Mice
- Does Ribavirin Impact on the Hospital Course of Children With Respiratory Syncytial Virus (RSV) Infection? An Analysis Using the Pediatric Investigators Collaborative Network on Infections in Canada (PICNIC) RSV Database
- Antiviral chemotherapy and chemoprophylaxis